These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20012252)

  • 1. In response to Morris et al.'s "Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine".
    Gillman K
    J Med Toxicol; 2009 Dec; 5(4):259. PubMed ID: 20012252
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine.
    Morris E; Green D; Graudins A
    J Med Toxicol; 2009 Mar; 5(1):27-31. PubMed ID: 19191213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome with promethazine.
    Mendhekar DN; Andrade CR
    Aust N Z J Psychiatry; 2005 Apr; 39(4):310. PubMed ID: 15777370
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral Asenapine overdose leading to Neuroleptic Malignant Syndrome (NMS).
    Das S; Purushothaman ST; Bc M; Chatterjee SS; Kartha A; Rajan V
    Asian J Psychiatr; 2017 Dec; 30():31-32. PubMed ID: 28711682
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
    Stanfield SC; Privette T
    J Emerg Med; 2000 Nov; 19(4):355-7. PubMed ID: 11074330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome after an emergency operation for acute appendicitis perforation.
    Tunca A; Sen M; Dener C; Bozoklu A; Koçak OM
    Can J Surg; 2004 Dec; 47(6):470. PubMed ID: 15646452
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
    Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
    J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome induced by quetiapine overdose.
    Khan KH; Tham TC
    Br J Hosp Med (Lond); 2008 Mar; 69(3):171. PubMed ID: 18426017
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
    Freedman MD
    Md Med J; 1997 Aug; 46(7):357-9. PubMed ID: 9260471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
    Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
    Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy.
    Tenenbein M
    Pediatr Neurosci; 1985-1986; 12(3):161-4. PubMed ID: 3870437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of olanzapine in adolescent with bipolar disorder after neuroleptic malignant syndrome].
    Boarati MA; Fu-I L
    Braz J Psychiatry; 2008 Mar; 30(1):86. PubMed ID: 18373024
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine induced neuroleptic malignant syndrome.
    Patra BN; Khandelwal SK; Sood M
    Indian J Pharmacol; 2013; 45(1):98-9. PubMed ID: 23543750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome: a case that may shed new light into the etiology and treatment.
    Yildiz A; Alkin T; Ozerdem A; Sagduyu K; Demopulos CM
    Aust N Z J Psychiatry; 2003 Aug; 37(4):493-4. PubMed ID: 12873338
    [No Abstract]   [Full Text] [Related]  

  • 15. [A cocaine-induced variant of the neuroleptic malignant syndrome. A case study].
    Smidt MH; Collumbien EC
    Tijdschr Psychiatr; 2006; 48(5):399-404. PubMed ID: 16956032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
    Erermis S; Bildik T; Tamar M; Gockay A; Karasoy H; Ercan ES
    Clin Toxicol (Phila); 2007; 45(3):277-80. PubMed ID: 17453880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of hyperthermia in neuroleptic malignant syndrome and the use of bromocriptine.
    Gillman PK
    J Med Toxicol; 2010 Jun; 6(2):272-3. PubMed ID: 20361363
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
    Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR
    Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine and neuroleptic malignant syndrome.
    Tofler I
    Psychosomatics; 2002; 43(6):505-6; author reply 506. PubMed ID: 12444237
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome and its successful treatment with bromocriptine--a case report.
    Javed A; Chaudhry HR
    J Pak Med Assoc; 1991 Jan; 41(1):19-20. PubMed ID: 1672170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.